Lipocine Inc.
LPCNLipocine Inc.
NASDAQ
Healthcare
Biotechnology
$2.02
-7.23(-78.14%)
52W $2.05 – $11.26
AI-generated
Lipocine Inc.
Revenue breakdown: License (94.5%), Royalty (5.5%).
$11MMkt Cap
$2MRev TTM
-$10MNI TTM
-4.1xP/E TTM
Latest Earnings
10-K
FY FY2025Mar 9, 2026Lipocine Inc. reported a net loss of $9.6 million for fiscal year 2025, driven by an operating loss of $10.4 million. Total revenues were $2.0 million, consisting of $1.5 million in license revenue and $477,000 in royalty revenue. Operating expenses totaled $12.3 million, with research and development costs of $8.6 million and general and administrative expenses of $3.8 million. The...
What Changed Recently
Fundamentals
How The Business Makes Money
Revenue by Segment
License94.5%($13M)
Royalty5.5%($774.8K)
Analyst View
Company Profile
CIK0001535955
ISINUS53630X2036
CUSIP53630X104
Phone801 994 7383
Address675 Arapeen Drive, Salt Lake City, UT, 84108, US
SEC EDGAR